The team behind this 8,500-sq-m single-use, monoclonal antibody biotech production facility for animal medication needed to meet its schedule targets so the owner could meet the earliest possible product-to-market date.
Source: New feed
The team behind this 8,500-sq-m single-use, monoclonal antibody biotech production facility for animal medication needed to meet its schedule targets so the owner could meet the earliest possible product-to-market date.
Source: New feed